Anjali Aryamvally's Profile
B.Tech (Genetic Engineering)
![Anjali Aryamvally Anjali Aryamvally](https://www.medindia.net/images/content-team-medindia/anjali-aryamvally.jpg)
Anjali is an undergraduate in Genetic Engineering from SRM University, Chennai. She is passionate about bringing changes in healthcare through a combination of genetics and social work. Anjali is an avid reader who enjoys writing. Her hobbies include gardening and traveling.
Written / Edited / Medically Reviewed
![GSK’s Gene Therapy, Strimvelis, for “Bubble Baby Disease” Gets NICE’s Approval](https://www.medindia.net/health-images/nice-approves-glaxosmithklines-gene-therapy.jpg)
GSK’s Gene Therapy, Strimvelis, for “Bubble Baby Disease” Gets NICE’s Approval
The National Institute for Health and Care Excellence has approved GSK’s gene therapy, Strimvelis, as an option to treat a rare immune deficiency condition.
![Improving Working Memory The Dual N-Back Brain Training Way](https://www.medindia.net/health-images/dual-n-back-brain-training-method.jpg)
Improving Working Memory The Dual N-Back Brain Training Way
Scientists have discovered that the dual n-back brain-training method improved working memory to a greater extent than the complex span method.
![Risk of Dialysis in Kidney Patients After Transcatheter Aortic Valve Replacement](https://www.medindia.net/health-images/transcatheter-aortic-valve-replacement.jpg)
Risk of Dialysis in Kidney Patients After Transcatheter Aortic Valve Replacement
Patients with advanced chronic kidney disease who undergo TAVR are more prone to start dialysis after the operation compared to those with early stage disease.
![October is Here! Let's Pass the Word on Rett Syndrome](https://www.medindia.net/health-images/rett-syndrome.jpg)
October is Here! Let's Pass the Word on Rett Syndrome
Let’s buckle up and spread awareness about Rett syndrome, a rare genetic disease resulting in neurodevelopmental delays.
![Phase 2 Clinical Trials of Two Candidate Ebola Vaccines in Liberia](https://www.medindia.net/health-images/candidate-ebola-vaccines.jpg)
Phase 2 Clinical Trials of Two Candidate Ebola Vaccines in Liberia
A phase 2 clinical trial of two candidate Ebola vaccines in Liberia showed that the vaccines are safe and response lasts at least for a year.